EXACT Therapeutics AS (OSL:EXTX)
Norway · Delayed Price · Currency is NOK 2.960
0.00 (0.00%)
At close: Aug 1, 2025
Inozyme Pharma Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
12
Market Cap
187.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 4.46K | -450.06K | -99.02% |
| Dec 31, 2022 | 454.52K | 402.52K | 774.07% |
| Dec 31, 2021 | 52.00K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 603.92M |
| Nordhealth AS | 545.88M |
| Photocure ASA | 532.69M |
| Vistin Pharma ASA | 440.66M |
| Omda AS | 442.14M |
| ArcticZymes Technologies ASA | 102.97M |
| Gentian Diagnostics ASA | 163.38M |
| Lytix Biopharma AS | 608.00K |